Where the country actually stands on psychedelics — policy, research, and harm reduction, state by state.
The House psychedelics caucus put a federal plan on paper
The FDA asked how psychedelic therapy should actually be delivered, and the public answered
The DEA tries again to ban five psychedelics, including one the FDA just fast-tracked
Oregon blinked on doubling its psilocybin fees, and the budget hole is still there
California's first state money for psychedelic research goes to veterans
Can psychedelic trials be blinded after all? Four researchers say try harder
Read The Trip Report No. 1 · September 22 – October 6, 2026 → · All issues